Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS)
$ 0.03845 -0.00344 (-8.21%) Market Cap: - Enterprise Value: - PE Ratio: 9,999.00 PB Ratio: 0 GF Score: 16/100

Ginkgo Bioworks Holdings Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 05:40PM GMT
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning. Thanks for joining us. I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs. I had the pleasure of welcoming Ginkgo Bioworks to our conference today, Anna Marie Wagner, Senior Vice President of Corporate Development. Anna Marie, thanks for joining us.

Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

Thanks for having me.

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if you could just kind of start out by sort of setting the stage and going over some of the key highlights this year, the opportunities ahead for Ginkgo. I mean, I know you've announced recently a couple of pretty important partnerships and maybe go through some of those.

Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

Sure. And I don't like to assume that people know

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot